Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference
NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference WALTHAM, Mass. --(BUSINESS WIRE)--Sep. 5, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes,
View HTML
Toggle Summary NeuroMetrix Receives 510(k) Clearance for SENSUS™ Pain Management Device
NeuroMetrix Receives 510(k) Clearance for SENSUS™ Pain Management Device WALTHAM, Mass. --(BUSINESS WIRE)--Aug. 6, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced
View HTML
Toggle Summary NeuroMetrix Reports Q2 2012 Results
Commercial Progress in Diabetes Market
View HTML
Toggle Summary Kenneth J. Snow, M.D., Chief Medical Officer of NeuroMetrix, Inc. Interviewed by KIDELA TV
Comments on Early Detection of Diabetes-Related Nerve Disease
View HTML
Toggle Summary NeuroMetrix, Inc. Announces Date for 2012 Second Quarter Financial Results Conference Call
NeuroMetrix, Inc. Announces Date for 2012 Second Quarter Financial Results Conference Call WALTHAM, Mass. --(BUSINESS WIRE)--Jul. 18, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2012 second quarter financial results before the opening of the market on July 26, 2012 .
View HTML
Toggle Summary NeuroMetrix, Inc. Announces Conference Call to Discuss American Diabetes Association 72nd Scientific Sessions and Other Business Activities
NeuroMetrix, Inc. Announces Conference Call to Discuss American Diabetes Association 72nd Scientific Sessions and Other Business Activities WALTHAM, Mass. --(BUSINESS WIRE)--Jun. 18, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , today said it will host a conference call at 10:00
View HTML
Toggle Summary NeuroMetrix to Exhibit at American Diabetes Association 72nd Scientific Sessions
Will Demonstrate NC-stat® DPNCheck™ and Provide First Look at SENSUS™ Pain Management Device
View HTML
Toggle Summary NeuroMetrix Engages IRG for Investor Relations
Initiates Campaign of Investor Outreach to Strengthen Company Awareness
View HTML
Toggle Summary NeuroMetrix Ships 500th Medical Device For Detecting Nerve Damage in Diabetics
NC-stat® DPNCheck&#8482 device addresses unmet medical need
View HTML
Toggle Summary NeuroMetrix to Exhibit at AACE Annual Meeting
Philadelphia, Pennsylvania May 23-27, 2012
View HTML